AU Stock MarketDetailed Quotes

NSB Neuroscientific Biopharmaceuticals Ltd

Watchlist
  • 0.045
  • +0.005+12.50%
20min DelayNot Open Jul 22 16:00 AET
6.51MMarket Cap-6428P/E (Static)

Neuroscientific Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities
4.95M
2,411.67%1.02M
19.77%40.54K
33.85K
Revenue from customers
--4.95M
----
2,411.67%1.02M
19.77%40.54K
--33.85K
Cash paid
-5.05%-7.36M
-92.21%-7.01M
-54.94%-3.65M
-54.24%-2.35M
-1.53M
Payments to suppliers for goods and services
-5.05%-7.36M
-92.21%-7.01M
-54.94%-3.65M
-54.24%-2.35M
---1.53M
Direct interest paid
---157
----
98.16%-63
-634.84%-3.42K
---465
Direct interest received
57.09%107.53K
147.60%68.45K
-22.63%27.65K
-58.18%35.73K
--85.44K
Operating cash flow
66.81%-2.3M
-166.85%-6.94M
-14.04%-2.6M
-62.09%-2.28M
---1.41M
Investing cash flow
Cash flow from continuing investing activities
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
-19.08K
Net PPE purchase and sale
----
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
---19.08K
Cash from discontinued investing activities
Investing cash flow
----
87.06%-3.87K
-1,154.32%-29.88K
87.52%-2.38K
---19.08K
Financing cash flow
Cash flow from continuing financing activities
1,305.79%13.51M
-83.80%960.8K
5.93M
Net common stock issuance
----
----
1,305.79%13.51M
-83.80%960.8K
--5.93M
Cash from discontinued financing activities
Financing cash flow
----
----
1,305.79%13.51M
-83.80%960.8K
--5.93M
Net cash flow
Beginning cash position
-49.05%7.22M
330.88%14.16M
-28.70%3.29M
4,336.85%4.61M
--103.9K
Current changes in cash
66.83%-2.3M
-163.87%-6.95M
922.14%10.88M
-129.36%-1.32M
--4.51M
End cash Position
-31.93%4.91M
-49.05%7.22M
330.88%14.16M
-28.70%3.29M
--4.61M
Free cash from
66.83%-2.3M
-163.97%-6.95M
-15.23%-2.63M
-60.09%-2.28M
---1.43M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Operating cash flow (direct method)
Cash income from operating activities 4.95M2,411.67%1.02M19.77%40.54K33.85K
Revenue from customers --4.95M----2,411.67%1.02M19.77%40.54K--33.85K
Cash paid -5.05%-7.36M-92.21%-7.01M-54.94%-3.65M-54.24%-2.35M-1.53M
Payments to suppliers for goods and services -5.05%-7.36M-92.21%-7.01M-54.94%-3.65M-54.24%-2.35M---1.53M
Direct interest paid ---157----98.16%-63-634.84%-3.42K---465
Direct interest received 57.09%107.53K147.60%68.45K-22.63%27.65K-58.18%35.73K--85.44K
Operating cash flow 66.81%-2.3M-166.85%-6.94M-14.04%-2.6M-62.09%-2.28M---1.41M
Investing cash flow
Cash flow from continuing investing activities 87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K-19.08K
Net PPE purchase and sale ----87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K---19.08K
Cash from discontinued investing activities
Investing cash flow ----87.06%-3.87K-1,154.32%-29.88K87.52%-2.38K---19.08K
Financing cash flow
Cash flow from continuing financing activities 1,305.79%13.51M-83.80%960.8K5.93M
Net common stock issuance --------1,305.79%13.51M-83.80%960.8K--5.93M
Cash from discontinued financing activities
Financing cash flow --------1,305.79%13.51M-83.80%960.8K--5.93M
Net cash flow
Beginning cash position -49.05%7.22M330.88%14.16M-28.70%3.29M4,336.85%4.61M--103.9K
Current changes in cash 66.83%-2.3M-163.87%-6.95M922.14%10.88M-129.36%-1.32M--4.51M
End cash Position -31.93%4.91M-49.05%7.22M330.88%14.16M-28.70%3.29M--4.61M
Free cash from 66.83%-2.3M-163.97%-6.95M-15.23%-2.63M-60.09%-2.28M---1.43M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg